VYNE Therapeutics VYNE reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
VYNE Therapeutics beat estimated earnings by 23.53%, reporting an EPS of $-0.13 versus an estimate of $-0.17.
Revenue was down $4.13 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.26 which was followed by a 7.25% increase in the share price the next day.
Here's a look at VYNE Therapeutics's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.16 | -0.24 | -0.32 | -0.35 |
| EPS Actual | 0.10 | -0.20 | -0.36 | -0.35 |
| Revenue Estimate | 370K | 4.12M | 4.76M | 6.21M |
| Revenue Actual | 178K | 2.29M | 4.09M | 4.26M |
To track all earnings releases for VYNE Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
